Supplemental materialS and metHOdS
reverse (P1R), 5-CGTGGATCACTTCTGTCACCGTTTCGC-3; P2F, 5-CTGAAAAACAGACTCGGGAAGAACG-3; P2R, 5-AAACTCTGTGGTCTGGCCTCTGGG-3; P3F, 5-GATAAAATACATCCAAATCAAGTTTGTTCG-3; P3R, 5-AAACTCTGTGGTCTGGCCTCTGGG-3; periostin (RD1) F, 5-GGAATTCGGCATTGTGGGAGCCAC-TACC-3; periostin (RD1) R, 5-GGTCGACTCAAATTTGTGTCAGGACACGGTC-3; aMHC F, 5-CTGCTG-GAGAGGTTATTCCTCG-3; aMHC R, 5-GGAAGAGTGAGCGGCGCATCAAGG-3; FSP-1 F, 5-AGCACTTCCTCTCTCTTGGTCTGGTC-3; FSP-1 R, 5-CACTGGCAAACTACACCCCAACAC-3; GAPDH F, 5-ACTTTGTCAAGCTCATTTCC-3; and GAPDH R, 5-TGCAGCGAACTTTATTGATG-3.
Ligation of left coronary artery. Induction of AMI was performed as previously described (4) . In brief, during anesthesia, 8-wk-old male mice were intubated and connected to a rodent ventilator (SAR-830AP; CWE Inc.). A median thoracotomy was performed, and the left anterior descending artery was identified. Afterward, a 7-0 nylon suture was passed around the artery, and subsequently tied off. Infarction was evident from discoloration of the LV. Finally, the chest wall was closed. Physiological measurements and histological and biological analyses were performed only on surviving mice. Using mid-part sections from at least 5 mice, we determined the infarct size by the previously described method (4).
Echocardiographic and hemodynamic measurements. The echocardiographic system was equipped with an 11 MHz transducer (EnVisor M2540A; Philips). Two-dimensional short-axis views of the LV were obtained. M-mode tracing was recorded through the anterior and posterior LV walls. LV diastolic and systolic internal dimensions (LVESD and LVEDD) were measured. LV percentage of fractional shortening (FS) was calculated as ([LVEDD  LVESD]/LVEDD)  100.
LV distending pressure/rupture threshold study. Periostin +/+ and / mice were killed 4 d after AMI, and the infarcted hearts were harvested. The rupture threshold stiffness of LVs was determined as previously described (5).
Myeloperoxidase assay. A myeloperoxidase assay, which is an index of neutrophil infiltration in the infarct hearts, was performed as previously described (6) . Infarcted hearts were weighed and frozen at 70°C, and 50 mg of the frozen tissue was sequentially homogenized in 1 ml of HTAB buffer (0.5% of HTAB and 50 mM Na 2 HPO 4 , pH 5.4), sonicated, subjected to 3 rounds of freezing/thawing, and then centrifuged at 20,000 g for 5 min. 10 l of supernatant was transferred into a flatbottomed 96-well plate, and 200 µl of O-dianisidine hydrochloride solution (1.76 mg/ml of O-dianisidine in 50 mM Na 2 HPO 4 , pH 5.4) was added immediately. After incubation, the absorbance was measured at 450 nm.
Cell culture. Primary adult ventricular cardiac fibroblasts were isolated from periostin +/+ and / mice and maintained as previously described (7) . C3H10T1/2 cells were grown in DME supplemented with 10% FNS (Invitrogen). Cells were transfected with siRNA oligonucleotides at 50 nM (SMARTpool; Dharmacon) by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The accession numbers of SMART pool siRNA oligonucleotides were as follows: L-041099-00 for fak and L-046779-01 for av-integrin. SH-6 (10 mM; an Akt inhibitor), PP2 (10 mM; a Src and FAK tyrosine kinase inhibitor; Calbiochem), Akt 1/2 inhibitor (10 mM; Sigma-Aldrich), or Geneticin (10 mM; a tyrosine kinase inhibitor; Fujicco) was added 30 min before stimulation.
Western blotting. PVDF membranes were probed with antibodies against phosphor-Akt (Ser 437), total Akt (Cell Signaling Technology), phosphor-FAK (Tyr 397; Biosource), total FAK (BD Biosciences), b-actin (Sigma-Aldrich), or mouse periostin (our laboratory).
In vitro cell migration assay. Cardiac fibroblasts from 8-wk-old periostin / mice were harvested and washed twice in serum-free DME containing 0.1% BSA (DME-BSA). Final volumes were adjusted for all cell preparations to be 1.0 × 10 5 cells/ml. 2.5 × 10 4 cells were added to each upper chamber of a 24-well transwell chamber (BD Biosciences) and allowed to migrate from DME-BSA-(upper chambers) to DMEM-BSA-containing medium conditioned by periostin DbDe-or empty vector-transfected HEK293T cells (lower chambers). As inhibiting molecules, 10 µg/ml anti-periostin (R&D Systems) and 10 µg/ml anti-av-integrin (CHEMICON Intenational, Inc.) antibodies, 10 mM PP2, or 50 nM siRNAs were used. After incubation for 24 h, migrating cells were fixed and stained with Giemsa solution. The net number of cells that had migrated completely through the 8-mm pores was determined in 10 random high-power fields (400×) for each filter. The migration assays were performed in triplicate.
TGFb-neutralizing antibody treatment. Wild-type male mice received intraperitoneal injections of TGFb-neutralizing antibody (R&D Systems) once every 7 d starting at 7 wk of age. Both TGFb 1 and 2 are known to be neutralized in vivo and in vitro by this antibody (8) . We diluted the antibody in PBS and administered it at a dose of 5 mg/kg body weight. Rabbit IgG (5 mg/kg; Sigma-Aldrich) was used in a similar fashion as a negative control. Induction of AMI was performed at 8 wk of age. Mice were killed 5 d after AMI, and we used 5 mice per group for histological analysis. 
